The expanding role of active surveillance in urology

It is fascinating to see that, as urologists have begun to understand and accept the viability and value of active surveillance (“expectant management”) in management of prostate cancer, they are beginning to see other uses for this strategy too. … READ MORE …

Quality of life after three different first-line radiation therapies for localized disease: Part 3

This is the third and last of three reports discussing a recent, detailed paper by Evans et al. The first (Part 1) was published on Tuesday, August 25, and Part 2 on Wednesday, August 26. … READ MORE …

The evolution of nuclear imaging in the management of prostate cancer

What is properly known as “nuclear imaging” is the use of (usually injectable) radioactive compounds into the body that have no known clinical effects but which can be targeted to “light up” and demonstrate the presence of specific types of tissue. … READ MORE …

Quality of life after three different first-line radiation therapies for localized disease: Part 2

This is the second of three reports discussing a recent, detailed paper by Evans et al. The first (Part 1) was published yesterday, on Tuesday, August 25, and Part 3 will be published tomorrow (Thursday, August 27). … READ MORE …

Expectations and realities: are we really helping couples to cope post-treatment?

A recent review in the journal Translational Andrology and Urology, which is reprinted on line on the Medscape Oncology web site, addresses the issue of “Couples-based interventions following prostate cancer treatment.” … READ MORE …

Quality of life after three different first-line radiation therapies for localized disease: Part 1

Some of the leading lights in radiation oncology have collaborated on a study (by Evans et al.) of patient-reported quality of life (QOL) following various primary radiation treatments for prostate cancer. … READ MORE …

Legal risk for physicians and use/non-use of PSA testing

Dr. Gerald Chodak has raised an interesting reason why physicians may want to think hard about the U.S. Preventive Services Task Force’s recommendation on the value of PSA testing for risk of prostate cancer. … READ MORE …

Follow

Get every new post delivered to your Inbox.

Join 1,351 other followers